Loading institutional data...
Loading institutional data...
Held by 221 of 2,417 reporting institutions (95th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $402.9M buybacks = $402.9M returned on $1.07B FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 7%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $677.46 today, the market must believe free cash flow compounds 13.5%/yr for a decade (off $967.8M on the 3-yr avg basis).
The market's 13.5% is more conservative than its 9-yr track record.
Default is 9.2% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.05B shares (market data) · net debt $2.12B
mean 24.5% · volatility σ 37% · implied rate exceeded in 6/9 yrs
Central path = implied 13.5%/yr growth; shaded band = ±1σ (37%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $352.4M is below the $450.1M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-28 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~2.4% on $2.48B of debt.
Cash of $352.4M is below short-term debt of $450.1M — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Ranked against 39 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYK | $119.6B | 37.1× | 20.4× | 4.8× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 1.8× | 738 |
| TT | $94.9B | 33.2× | 23.4× | 4.5× | 7.5% | — | 13.7% | 34.0% | 22.1% | 0.7× | 570 |
| MMM | $91.5B | 29.6× | 17.5× | 3.7× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 788 |
| NOC | $79.9B | 19.3× | 15.2× | 1.9× | 2.2% | — | 10.0% | 25.1% | 12.9% | 1.9× | 576 |
| BSX | $61.9B | 22.0× | 12.1× | 3.1× | 19.9% | 69.0% | 14.4% | 11.9% | 11.8% | -0.3× | 407 |
| AME | $57.7B | 39.3× | 29.0× | 7.8× | 6.6% | 36.0% | 20.0% | 13.9% | 11.5% | 0.9× | 337 |
| KEYS | $56.2B | 67.2× | 56.4× | 10.4× | 8.0% | 62.1% | 15.8% | 14.5% | 10.1% | 0.7× | 354 |
| EW | $54.4B | 51.6× | 36.7× | 9.0× | 11.5% | 78.0% | 17.7% | 10.4% | 9.8% | -1.6× | 399 |
| BDX | $54.0B | 34.1× | 14.4× | 2.5× | 8.2% | 45.4% | 7.7% | 6.6% | 3.8% | 3.7× | 458 |
| GRMN | $53.9B | 32.6× | 25.5× | 7.5× | 15.1% | 58.7% | 23.0% | 18.5% | 18.5% | -1.1× | 324 |
| A | $51.1B | 39.6× | 29.8× | 7.3× | 6.7% | 52.4% | 18.8% | 19.3% | 12.9% | 0.9× | 357 |
| ROK | $50.1B | 58.9× | 26.1× | 6.0× | 0.9% | 48.1% | 10.4% | 23.8% | 12.6% | 1.4× | 464 |
| WAT | $47.1B | 44.6× | 53.3× | 14.9× | 7.0% | 59.3% | 20.3% | 25.1% | 18.3% | 0.4× | 360 |
| COHR | $46.7B | 57.6× | — | 6.6× | 22.5% | 37.5% | 11.3% | 7.4% | 5.7% | — | 334 |
| TER | $46.3B | 85.4× | 59.4× | 14.5× | 13.1% | 58.2% | 17.4% | 19.8% | 18.5% | -0.1× | 385 |
| ROP | $44.5B | 31.7× | 17.1× | 5.6× | 12.3% | 69.2% | 19.4% | 7.7% | 5.3% | 2.9× | 303 |
| ILMN | $43.8B | 53.2× | 40.7× | 10.1× | -0.7% | 66.1% | 19.6% | 31.2% | 31.2% | 0.0× | 308 |
| RMD | $35.6B | 24.2× | 16.6× | 6.3× | 9.9% | 61.1% | 26.9% | 23.1% | 21.0% | -0.4× | — |
| GEHC | $34.6B | 16.8× | 13.1× | 1.7× | 4.8% | 40.0% | 10.1% | 20.1% | 10.2% | 1.8× | 356 |
| MTD | $34.4B | 40.9× | 33.8× | 8.6× | 4.0% | 59.4% | 21.6% | — | 40.8% | 2.0× | 195 |
| TDY | $31.4B | 35.9× | 26.4× | 5.1× | 7.9% | 42.8% | 14.6% | 8.5% | 6.9% | 1.7× | 221 |
| DXCM | $30.2B | 38.2× | 25.1× | 6.5× | 15.6% | 60.1% | 17.9% | 30.5% | 30.5% | -0.8× | 287 |
| WST | $29.3B | 61.4× | 38.0× | 9.5× | 6.3% | 35.9% | 16.1% | 15.5% | 14.6% | -0.8× | 237 |
| MDLN | $28.1B | — | 12.0× | 1.0× | — | 26.4% | 4.1% | 10.8% | 5.0% | 3.3× | 84 |
| VLTO | $25.4B | 27.7× | 19.2× | 4.6× | 6.0% | 59.9% | 17.1% | 30.3% | 16.3% | 0.5× | 282 |
Peers = companies sharing TDY's sector (Search, Detection, Navigation, Guidance, Aeronautical Sys) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
EOD close · as of 2026-10-29
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.12B 100.0% | $5.67B 100.0% | $5.64B 100.0% | $5.46B 100.0% | $4.61B 100.0% | $3.09B 100.0% | $3.16B 100.0% | $2.90B 100.0% | $2.60B 100.0% | $2.15B 100.0% |
| Cost of Revenue | $3.50B 57.2% | $3.24B 57.1% | $3.20B 56.7% | $3.13B 57.3% | $2.77B 60.1% | $1.91B 61.7% | $1.92B 60.7% | $1.79B 61.7% | $1.62B 62.4% | $1.33B 61.8% |
| Research & Development | $317.3M 5.2% | $292.6M 5.2% | $356.3M 6.3% | $352.2M 6.5% | — | — | — | — | — | — |
| Selling, General & Admin | $931.1M 15.2% | $902.6M 15.9% | $852.0M 15.1% | $804.0M 14.7% | $1.07B 23.1% | $662.0M 21.5% | $715.1M 22.6% | $694.2M 23.9% | $658.1M 25.3% | $579.9M 27.0% |
| Total Operating Expenses | $4.97B 81.2% | $4.68B 82.6% | $4.60B 81.6% | $4.49B 82.2% | $3.99B 86.5% | $2.61B 84.4% | $2.67B 84.5% | $2.49B 85.6% | $2.28B 87.6% | $1.91B 88.8% |
| Operating Income | $1.15B 18.8% | $989.1M 17.4% | $1.03B 18.4% | $972.0M 17.8% | $624.3M 13.5% | $480.1M 15.6% | $491.7M 15.5% | $416.6M 14.4% | $321.7M 12.4% | $240.5M 11.2% |
| Interest Expense | $59.6M 1.0% | $57.9M 1.0% | $77.3M 1.4% | $89.3M 1.6% | $90.8M 2.0% | $15.3M 0.5% | $21.0M 0.7% | $29.2M 1.0% | $35.5M 1.4% | $23.6M 1.1% |
| Other Income (Expense), net | -$21.6M -0.4% | -$4.1M -0.1% | -$12.2M -0.2% | $3.4M 0.1% | $2.5M 0.1% | -$7.2M -0.2% | -$5.0M -0.2% | -$10.7M -0.4% | -$15.5M -0.6% | $10.7M 0.5% |
| Pretax Income | $1.09B 17.9% | $937.9M 16.5% | $958.9M 17.0% | $908.1M 16.6% | $533.8M 11.6% | $469.7M 15.2% | $473.7M 15.0% | $393.9M 13.6% | $287.0M 11.0% | $241.3M 11.2% |
| Income Tax Expense | $198.8M 3.3% | $117.2M 2.1% | $72.3M 1.3% | $119.2M 2.2% | $88.5M 1.9% | $67.8M 2.2% | $71.4M 2.3% | $60.1M 2.1% | $59.8M 2.3% | $50.4M 2.3% |
| Net Income | $894.8M 14.6% | $819.2M 14.4% | $885.7M 15.7% | $788.6M 14.4% | $445.3M 9.7% | $401.9M 13.0% | $402.3M 12.7% | $333.8M 11.5% | $227.2M 8.7% | $190.9M 8.9% |
| Per Share | ||||||||||
| EPS (Basic) | $19.12 | $17.43 | $18.80 | $16.85 | $10.31 | $10.95 | $11.08 | $9.32 | $6.45 | $5.52 |
| EPS (Diluted) | $18.88 | $17.21 | $18.49 | $16.53 | $10.05 | $10.62 | $10.73 | $9.01 | $6.26 | $5.37 |
| Weighted Avg Shares (Basic) | 46.8M | 47.0M | 47.1M | 46.8M | 43.2M | 36.7M | 36.3M | 35.8M | 35.2M | 34.6M |
| Weighted Avg Shares (Diluted) | 47.4M | 47.6M | 47.9M | 47.7M | 44.3M | 37.9M | 37.5M | 37.0M | 36.3M | 35.5M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-10-29
Where each multiple sits in its own 14-yr range · 87th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 9% against ROIC 7% — 2% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 2.1× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2021 | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 61.7 | 60.7 | 61.7 | 60.1 | 57.3 | 56.7 | 57.1 | 57.2 |
| R&D | — | — | — | — | 6.5 | 6.3 | 5.2 | 5.2 |
| SG&A | 23.9 | 22.6 | 21.5 | 23.1 | 14.7 | 15.1 | 15.9 | 15.2 |
| Operating Income | 14.4 | 15.5 | 15.6 | 13.5 | 17.8 | 18.4 | 17.4 | 18.8 |
| Income Tax | 2.1 | 2.3 | 2.2 | 1.9 | 2.2 | 1.3 | 2.1 | 3.3 |
| Net Income | 11.5 | 12.7 | 13.0 | 9.7 | 14.4 | 15.7 | 14.4 | 14.6 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on TDY: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns -1.37pts against its cost of capital — capital is being consumed, not created.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 12.0% | 9.2% (today's — no rate published for this year) | 2.8pts |
| FY2021 | 11.9% | 9.2% (today's — no rate published for this year) | 2.6pts |
| FY2022 | 4.7% | 7.2% | -2.4pts |
| FY2023 | 7.2% | 8.3% | -1.0pts |
| FY2023 | 7.5% | 8.3% | -0.8pts |
| FY2024 | 7.3% | 8.6% | -1.3pts |
| FY2025 | 7.8% | 8.2% | -0.4pts |
| Now | 6.9% | 9.2% | -2.3pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2017 | 38.2% | 11.2% | 8.9% |
| FY2017 | 37.6% | 12.4% | 8.7% |
| FY2018 | 38.3% | 14.4% | 11.5% |
| FY2019 | 39.3% | 15.5% | 12.7% |
| FY2021 | 38.3% | 15.6% | 13.0% |
| FY2022 | 39.9% | 13.5% | 9.7% |
| FY2023 | 42.7% | 17.8% | 14.4% |
| FY2023 | 43.3% | 18.4% | 15.7% |
| FY2024 | 42.9% | 17.4% | 14.4% |
| FY2025 | 42.8% | 18.8% | 14.6% |
Return on equity (9%) and return on invested capital (7%) are within a couple of points in FY2025, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
$8.7B of goodwill — 68% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer. With goodwill over half the base, the ex-goodwill figure divides by a small remainder and moves sharply — read it as a direction, not a precise rate.
ROIC ex-goodwill is 24.53% against 7.86% reported — the return is earned on a capital base inflated by what was paid for acquisitions, not by the operating business alone.
Converts 1.10x of reported profit into cash — adequate, without much margin.
The cash conversion cycle has lengthened +13 days over 3 years to 117 — that many more days of the company's own cash funding the same volume of business.
Missing from our data, so excluded from this answer: share_based_compensation.
Covers interest 13.5x even after a 30% EBITDA decline.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 19.29x |
| 5% | 18.33x |
| 10% | 17.36x |
| 15% | 16.40x |
| 20% | 15.43x |
| 25% | 14.47x |
| 30% | 13.50x |
| 35% | 12.54x |
| 40% | 11.58x |
| 45% | 10.61x |
| 50% | 9.65x |
| 55% | 8.68x |
| 60% | 7.72x |
Ladder as of 2025-12-28 (10-K); cash from the 2025-12-28 balance sheet; FCF from FY2025.
Balance sheet at 2025-12-28. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
The maturity schedule is not part of this verdict — its filing anchor is often older than the balance sheet it sits beside, so a wall inside 24 months may not be visible here.
At $677.46, free cash flow must compound 13.52%/yr for 10 years. It has done 18.21%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2021 | 39.1% | 13.5% |
| FY2022 | 32.1% | 13.5% |
| FY2023 | −45.5% | 13.5% |
| FY2023 | 83.0% | 13.5% |
| FY2024 | 53.7% | 13.5% |
| FY2025 | −3.1% | 13.5% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
The implied rate has been matched or beaten in 4 of the last 6 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $895M | $895M |
| Share-based comp | not reported | not reported |
| Other non-cash & working capital | $297M | $1.19B |
| Operating cash flow | $1.19B | $1.19B |
| Capex | −$117M | $1.07B |
| Free cash flow | $1.07B | $1.07B |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2021 | -2.5% | -12.7% | -10.2 points |
| FY2022 | 49.5% | 91.0% | 41.5 points |
| FY2023 | 18.3% | 15.1% | -3.2 points |
| FY2023 | 3.2% | 1.8% | -1.4 points |
| FY2024 | 0.6% | 0.2% | -0.4 points |
| FY2025 | 7.9% | 10.1% | 2.3 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 53.1 days | 74.8 days | 51.5 days | 76.4 days |
| FY2021 | 47.5 days | 66.5 days | 43.9 days | 70.2 days |
| FY2022 | 60.7 days | 99.1 days | 61.8 days | 98 days |
| FY2023 | 59.1 days | 103.9 days | 59 days | 104 days |
| FY2023 | 58.3 days | 104.8 days | 43.9 days | 119.1 days |
| FY2024 | 58 days | 103.2 days | 47 days | 114.2 days |
| FY2025 | 59.2 days | 108.8 days | 50.7 days | 117.3 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -1.7 percent |
| FY2021 | -4.3 percent |
| FY2022 | -2.6 percent |
| FY2023 | 2.1 percent |
| FY2023 | 0.3 percent |
| FY2024 | -2.6 percent |
| FY2025 | -1.9 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 6 consecutive years to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-12 | 4 co-filers Group filing | Open-market sale | 3,451 | $679.74 | $2.3m |
| 2026-08-12 | Von Schack Wesley W Director | Open-market sale | 468 | $686.63 | $321k |
| 2026-08-12 | 4 co-filers Group filing | Open-market sale | 2,000 | $680.18 | $1.4m |
| 2026-08-12 | 4 co-filers Group filing | Open-market sale | 40 | $681.79 | $27k |
| 2026-08-12 |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
4 co-filers Group filing |
| Open-market sale |
| 958 |
| $682.81 |
| $654k |
| 2026-04-22 | Cibik Melanie Susan EVP, GenCounsel, CCO & Sec. | Grant | 2,138 | $0.00 | — |
| 2026-04-22 | Blackwood Stephen Finis Executive VP and CFO | Grant | 2,470 | $0.00 | — |
| 2026-04-22 | Belak Cynthia Y Senior VP and Controller | Grant | 1,255 | $0.00 | — |
| 2026-04-22 | 5 co-filers Vice Chairman | Option exerciseindirect | 126 | $0.00 | $0 |
| 2026-04-22 | Morales Vincent J Director | Grant | 319 | $0.00 | $0 |
| 2026-04-22 | Kumbier Michelle Director | Grant | 319 | $0.00 | $0 |
| 2026-04-22 | Black Laura A. Director | Grant | 319 | $0.00 | $0 |
| 2026-04-22 | Malone Robert A Director | Grant | 319 | $0.00 | $0 |
| 2026-04-22 | Sherburne Jane Cecile Director | Grant | 319 | $0.00 | $0 |
| 2026-04-22 | Lorne Simon M Director | Grant | 319 | $0.00 | $0 |
| 2026-04-22 | Smith Michael T Director | Grant | 319 | $0.00 | $0 |
| 2026-04-22 | Von Schack Wesley W Director | Grant | 319 | $0.00 | $0 |
| 2026-04-22 | Bobb George C Iii President and CEO | Grant | 5,515 | $0.00 | — |
| 2026-04-22 | Mehrabian Robert Executive Chairman | Grant | 5,633 | $0.00 | — |
| 2026-04-22 | 5 co-filers Vice Chairman | Tax withholdingindirect | 65 | $0.00 | $0 |
| 2026-04-22 | 5 co-filers Vice Chairman | Grant | 2,415 | $0.00 | — |
| 2026-04-22 | 5 co-filers Vice Chairman | Grantindirect | 272 | $0.00 | — |
| 2026-04-22 | 5 co-filers Vice Chairman | Option exerciseindirect | 126 | $0.00 | — |
| 2026-02-03 | 8 co-filers Vice Chairman | Option exercise | 5,000 | $192.00 | $960k |
| 2026-02-03 | 8 co-filers Vice Chairman | Exercise & sell | 2,580 | $630.49 | $1.6m |
| 2026-02-03 | 8 co-filers Vice Chairman | Exercise & sell | 2,420 | $631.39 | $1.5m |
| 2026-02-03 | 8 co-filers Vice Chairman | Option exerciseindirect | 2,500 | $123.38 | $308k |
| 2026-02-03 | 8 co-filers Vice Chairman | Exercise & sellindirect | 2,220 | $630.39 | $1.4m |
| 2026-02-03 | 8 co-filers Vice Chairman | Exercise & sellindirect | 280 | $631.07 | $177k |
| 2026-02-03 | 8 co-filers Vice Chairman | Option exercise | 5,000 | $0.00 | — |
| 2026-02-03 | 8 co-filers Vice Chairman | Option exerciseindirect | 2,500 | $0.00 | — |
| 2026-01-29 | 2 co-filers Group filing | Open-market sale | 2,469 | $621.00 | $1.5m |
| 2026-01-28 | 2 co-filers Group filing | Open-market sale | 1,531 | $621.00 | $951k |
| 2026-01-24 | 2 co-filers EVP, GenCounsel, CCO & Sec. | Other | 165 | $0.00 | $0 |
| 2026-01-24 | 2 co-filers Executive VP and CFO | Other | 137 | $0.00 | $0 |
| 2026-01-24 | 2 co-filers Senior VP and Controller | Other | 131 | $0.00 | $0 |
| 2026-01-24 | 5 co-filers Vice Chairman | Other | 184 | $0.00 | $0 |
| 2026-01-24 | 2 co-filers President and CEO | Other | 239 | $0.00 | $0 |
| 2026-01-24 | 2 co-filers Executive Chairman | Other | 1,350 | $0.00 | $0 |
| 2026-01-24 | 2 co-filers Senior VP and Controller | Tax withholding | 118 | $0.00 | $0 |